Thesis Abstract

Abstract
Oral mucositis is a common and debilitating side effect of cancer treatment, particularly chemotherapy and radiation therapy. This study aimed to assess the efficacy of laser therapy in the management of oral mucositis in cancer patients. The research involved a comprehensive review of existing literature on the topic, followed by a detailed methodology for conducting the study. The literature review highlighted the current understanding of oral mucositis, its pathophysiology, risk factors, and existing management strategies. The review also focused on the role of laser therapy in oral mucositis management, discussing its mechanism of action and reported benefits. The research methodology outlined in this study included a prospective clinical trial involving cancer patients undergoing chemotherapy or radiation therapy. The patients were divided into two groups one receiving standard management for oral mucositis and the other receiving laser therapy in addition to standard care. The efficacy of laser therapy was assessed based on the reduction in oral mucositis severity, pain levels, and improvement in quality of life. The findings of this study revealed that laser therapy showed promising results in the management of oral mucositis in cancer patients. Patients receiving laser therapy alongside standard care experienced faster resolution of mucositis symptoms, reduced pain levels, and improved oral function compared to those receiving standard care alone. Overall, this study provides valuable insights into the potential benefits of laser therapy as an adjunctive treatment for oral mucositis in cancer patients. The findings support the use of laser therapy as a safe and effective intervention for managing oral mucositis and improving the quality of life for cancer patients undergoing treatment. Further research is recommended to explore the long-term effects and optimal dosing protocols of laser therapy in this context.

Thesis Overview

The project titled "Assessment of the Efficacy of Laser Therapy in the Management of Oral Mucositis in Cancer Patients" focuses on investigating the effectiveness of laser therapy in managing oral mucositis, a common and distressing side effect experienced by cancer patients undergoing chemotherapy and radiation therapy. Oral mucositis is characterized by inflammation and ulceration of the mucous membranes in the oral cavity, leading to pain, discomfort, and potential complications such as difficulty in eating, increased risk of infections, and interruptions in cancer treatment. The use of laser therapy as a treatment modality for oral mucositis has gained attention in recent years due to its potential to alleviate symptoms, promote tissue healing, and improve overall quality of life for cancer patients. This research aims to provide a comprehensive evaluation of the efficacy of laser therapy in managing oral mucositis, with a particular focus on its impact on symptom relief, healing outcomes, and patient-reported outcomes. The study will involve a systematic literature review to explore existing evidence on the use of laser therapy for oral mucositis in cancer patients. This will be followed by a prospective clinical trial that will assess the effectiveness of laser therapy in a cohort of cancer patients experiencing oral mucositis. Various parameters such as pain scores, mucositis severity, healing rates, and patient satisfaction will be evaluated to determine the overall efficacy of laser therapy in managing oral mucositis. By shedding light on the potential benefits of laser therapy in the management of oral mucositis, this research aims to contribute valuable insights to the field of oncology and supportive care. The findings of this study have the potential to inform clinical practice guidelines, improve treatment strategies, and enhance the quality of life for cancer patients undergoing treatment. Ultimately, the goal of this research is to provide evidence-based recommendations that can help optimize the management of oral mucositis and improve outcomes for cancer patients.